Reuters logo
BRIEF-Gensight Biologics FY net loss widens to 22.1 million euros
March 13, 2017 / 6:37 AM / 8 months ago

BRIEF-Gensight Biologics FY net loss widens to 22.1 million euros

March 13 (Reuters) - Gensight Biologics SA:

* Net loss in 2016 amounted to EUR 22.1 million ($23.65 million) compared with loss of EUR 13.7 million in 2015

* Operating income decreased by 15.7% from EUR 3.6 million in 2015 to EUR 3.0 million in 2016

* Net cash flows from financing activities increased to EUR 43.7 million in 2016 compared with EUR 30.9 million a year earlier Source text for Eikon: Further company coverage: ($1 = 0.9343 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below